Walleye Capital’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.25M Sell
8,806
-20,008
-69% -$5.31M 0.02% 929
2026
Q1
$3.16M Sell
28,814
-22,618
-44% -$3.22M 0.01% 1104
2025
Q4
$8.56M Sell
51,432
-49,773
-49% -$8.33M 0.03% 757
2025
Q3
$19.8M Buy
101,205
+77,996
+336% +$12.8M 0.07% 253
2025
Q2
$2.1M Sell
23,209
-61,234
-73% -$4.84M 0.01% 1478
2025
Q1
$5.04M Buy
84,443
+23,037
+38% +$2.13M 0.02% 780
2024
Q4
$8.13M Sell
61,406
-10,338
-14% -$970K 0.02% 768
2024
Q3
$3.76M Buy
71,744
+28,141
+65% +$1.32M 0.01% 1384
2024
Q2
$2.64M Sell
43,603
-6,397
-13% -$444K ﹤0.01% 1848
2024
Q1
$3.71M Buy
+50,000
New +$3.7M 0.01% 1528

Other funds holding ALAB

Walleye Capital's ALAB Position: Q2 2026 in Review

Walleye Capital reduced its Astera Labs (ALAB) stake by 69% in Q2 2026, selling an estimated $5.31M and leaving 8,806 shares worth $4.25M. The position accounts for 0.02% of the portfolio, ranked #929.

Walleye Capital first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $19.8M in Q3 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Walleye Capital held 8,806 shares of Astera Labs worth $4.25M as of Q2 2026.
  • Walleye Capital sold 20,008 Astera Labs shares in Q2 2026, an estimated $5.31M.
  • Astera Labs made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #929 holding.
  • Walleye Capital first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • Walleye Capital's Astera Labs position peaked at $19.8M in Q3 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.